You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune modulation therapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Conditioned Pain Modulation in Localized vs Widespread Chronic

Recruiting
  • Chronic Low-back Pain
  • Localized vs Widespread Mechanical Pain Hypersensitivity
  • Al Ḩayy Ath Thāmin, Giza, Egypt
    Outpatient clinic of faculty of physical therapy, Ahram Canadian
Jul 24, 2023

Recovery From Acute Immune Failure in Septic Shock by Immune

Recruiting
  • Severe Sepsis
    • Magdeburg, Germany
    • +1 more
    Nov 20, 2023

    Atopic Dermatitis Trial in Berlin (not applicable, observational study)

    Recruiting
    • Atopic Dermatitis
    • not applicable, observational study
    • Berlin, Germany
      Dpt of Dermatology and Allergology, Charité - Universitätsmedizi
    Oct 20, 2021

    Nasopharyngeal Cancer Trial in Shanghai (Toripalimab, Induction chemo and concurrent chemoradiation)

    Recruiting
    • Nasopharyngeal Cancer
    • Toripalimab
    • Induction chemotherapy and concurrent chemoradiation
    • Shanghai, Shanghai, China
      Fudan Universtiy Shanghai Cancer Centre
    Nov 25, 2022

    Covid-19 Patients Trial in Giza (Cupping therapy with convential medical treatment, Convential medical treatment)

    Completed
    • Covid-19 Patients
    • Cupping therapy with convential medical treatment
    • Convential medical treatment
    • Giza, Egypt
      Faculty of physical therapy
    Jun 11, 2023

    Immune System Disorder Trial in Giza (Aerobic training, diet protocol)

    Recruiting
    • Immune System Disorder
    • Aerobic training
    • diet protocol
    • Giza, Egypt
      Faculty of Physical therapy, Cairo University
    Nov 20, 2023

    Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Rozzano (Rituximab)

    Active, not recruiting
    • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
    • Rozzano, Milano, Italy
      Istituto Clinico Humanitas
    May 17, 2023

    Colon Cancer Trial in Boston (AMR101 (VASCEPA, icosapent ethyl))

    Withdrawn
    • Colon Cancer
    • AMR101 (VASCEPA, icosapent ethyl)
    • Boston, Massachusetts
      Massachusetts General Hospital
    Nov 10, 2021

    Immune Checkpoint Inhibitor Monotherapy or Combined With

    Not yet recruiting
    • Immune Checkpoint Inhibitor Monotherapy or Combined With Molecular Targeting Drugs / Locoregional Therapy for Hepatocellular Carcinoma
    • Immune checkpoint inhibitor
    • Guangzhou, Guangdong, China
      Department of Minimally Invasive and Interventional Radiology, L
    Jan 30, 2023

    Neuropathic Pain, Phantom Limb Pain Trial in Mölndal (Mindful SensoriMotor Therapy Enhanced with Brain Modulation)

    Not yet recruiting
    • Neuropathic Pain
    • Phantom Limb Pain
    • Mindful SensoriMotor Therapy Enhanced with Brain Modulation
    • Mölndal, Västra Götaland, Sweden
      Center for Bionics and Pain Research, CBPR
    Mar 8, 2022

    Surgery, Immune System and Related Disorders, Preoperative Care Trial in Stanford (Physical Prehabilitation, Stress Reduction

    Recruiting
    • Surgery
    • +6 more
    • Physical Prehabilitation
    • +3 more
    • Stanford, California
      Stanford University
    Nov 26, 2021

    Last Period Not Earlier Than 6 Months Ago Trial in Moscow (oral menopausal hormone therapy, transdermal menopausal hormone

    Active, not recruiting
    • Last Period Not Earlier Than 6 Months Ago
    • oral menopausal hormone therapy
    • transdermal menopausal hormone therapy
    • Moscow, Russian Federation
      Federal State Budget Institution Research Center for Obstetrics,
    Jan 9, 2023

    Gastrointestinal Tumor Trial in Hangzhou (Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T,

    Completed
    • Gastrointestinal Tumor
    • Water-filtered infrared A radiation whole-body hyperthermia (HECKEL 3000MT-4T, Germany)
    • tislelizumab (BeiGene, China) combined with PD-1 inhibitor
    • Hangzhou, China
      Zhejiang Hospital
    Sep 1, 2023

    Neuroplastic Modulation in Central Auditory Tract

    Completed
    • Tinnitus
    • +4 more
    • Electroacupuncture
    • Taichung, Taiwan
      China Medical University
    Oct 19, 2022

    Immune-related Colitis, Colitis Trial in Minneapolis (RMT, Placebo)

    Not yet recruiting
    • Immune-related Colitis
    • Colitis
    • Minneapolis, Minnesota
      University of Minnesota
    Feb 4, 2023

    Metastatic Pancreatic Cancer Trial in Rotterdam (Durvalumab, Rintatolimod)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • Durvalumab
    • Rintatolimod
    • Rotterdam, Zuid-Holland, Netherlands
      Erasmus MC
    Jun 23, 2023

    Adjuvant Immune Checkpoint Inhibitors in Postoperative

    Recruiting
    • Hepatocellular Carcinoma
    • Immune Checkpoint Inhibitors Based Adjuvant therapy
    • Nanning, Guangxi, China
      Jian-Hong Zhong
    Jan 18, 2023

    Pediatric Cancer Trial in Charlotte (Vaccine)

    Recruiting
    • Pediatric Cancer
    • Vaccine
    • Charlotte, North Carolina
      Levine Cancer Institute
    Jan 27, 2023

    Immune Markers in Pediatric ITP

    Not yet recruiting
    • ITP - Immune Thrombocytopenia
    • complete blood count, CD3+ , CD4+ , CD8+, CD16+, CD56+, IFN-γ.
    • (no location specified)
    Oct 17, 2023

    Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

    Suspended
    • Anatomic Stage 0 Breast Cancer AJCC v8
    • +18 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Oct 4, 2022

    Determine Pro-Inflammatory Cytokine Kinetics During Immune

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • Melanoma
      • Indianapolis, Indiana
        Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
      Jan 30, 2023

      Hepatocellular Carcinoma, Secondary Malignant Tumor of Liver Trial in Minneapolis (Yttrium-90)

      Recruiting
      • Hepatocellular Carcinoma
      • Secondary Malignant Neoplasm of Liver
      • Yttrium-90
      • Minneapolis, Minnesota
        University of Minnesota
      Oct 21, 2021

      Sepsis, Severe Trial in Germany (ARTICE)

      Recruiting
      • Sepsis, Severe
      • ARTICE
      • Braunschweig, Germany
      • +3 more
      Jul 29, 2022

      Healthcare Resource Utilization and Costs of Immune Checkpoint

      Completed
      • Melanoma
        • East Hanover, New Jersey
          Novartis
        May 12, 2023

        Colorectal Cancer Stage IV Trial in Sherbrooke (Resting state (Control), Moderate Intensity Continuous Exercise (MICE), High

        Recruiting
        • Colorectal Cancer Stage IV
        • Resting state (Control)
        • +2 more
        • Sherbrooke, Quebec, Canada
          Research Centre on Aging
        May 16, 2022